Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 1711 AL 1725

Glucocerebrosidase mutations and the pathogenesis of Parkinson disease

Beavan MS, Schapira AH.

Ann Med. 2013 Dec;45(8):511-21. doi: 10.3109/07853890.2013.849003.

From prion diseases to prion-like propagation mechanisms of neurodegenerative diseases

Acquatella-Tran Van Ba I, Imberdis T, Perrier V.

Int J Cell Biol. 2013;2013:975832. doi: 10.1155/2013/975832. Epub 2013 Oct 10.

Molecular imaging in traditional Chinese medicine therapy for neurological diseases

Wang Z, Wan H, Li J, Zhang H, Tian M.

Biomed Res Int. 2013;2013:608430. doi: 10.1155/2013/608430. Epub 2013 Oct 7.

[An autopsy case of Alzheimer's disease presenting with corticobasal syndrome]

Fujii N, Wakamiya T, Watanabe A, Furuya H, Sasaki K, Iwaki T.

Rinsho Shinkeigaku. 2013;53(10):814-20. doi: 10.5692/clinicalneurol.53.814.

Dementia with Lewy bodies

Molano JR.

Semin Neurol. 2013 Sep;33(4):330-5. doi: 10.1055/s-0033-1359315. Epub 2013 Nov 14.

Frontotemporal dementia

Perry DC, Miller BL.

Semin Neurol. 2013 Sep;33(4):336-41. doi: 10.1055/s-0033-1359316. Epub 2013 Nov 14.

New and emerging treatments for symptomatic tardive dyskinesia

Rana AQ, Chaudry ZM, Blanchet PJ.

Drug Des Devel Ther. 2013 Nov 6;7:1329-40. doi: 10.2147/DDDT.S32328. eCollection 2013.

Nodding syndrome: origins and natural history of a longstanding epileptic disorder in sub-Saharan Africa

Spencer PS, Palmer VS, Jilek-Aall L.

Afr Health Sci. 2013 Jun;13(2):176-82. doi: 10.4314/ahs.v13i2.1.

A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson's disease

Troeung L, Egan SJ, Gasson N.

PLoS One. 2013 Nov 13;8(11):e79510. doi: 10.1371/journal.pone.0079510. eCollection 2013.

Effects of rotigotine transdermal system on non-motor symptoms in Parkinson's disease: an overview

Zesiewicz TA, Martinez-Martin P.

Expert Rev Neurother. 2013 Dec;13(12):1329-42. doi: 10.1586/14737175.2013.859986.

New immunological approaches in treating and diagnosing CNS diseases

Guo K, Janigro D.

Pharm Pat Anal. 2013 May;2(3):361-71. doi: 10.4155/ppa.13.16.

Metabotropic glutamate receptor 5-negative allosteric modulators for the treatment of psychiatric and neurological disorders (2009-July 2013)

Li G, Jørgensen M, Campbell BM.

Pharm Pat Anal. 2013 Nov;2(6):767-802. doi: 10.4155/ppa.13.58.

Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations

Alcalay RN, Mirelman A, Saunders-Pullman R, Tang MX, Mejia Santana H, Raymond D, Roos E, Orbe-Reilly M, Gurevich T, Bar Shira A, Gana Weisz M, Yasinovsky K, Zalis M, Thaler A, Deik A, Barrett MJ, Cabassa J, Groves M, Hunt AL, Lubarr N, San Luciano M, Miravite J, Palmese C, Sachdev R, Sarva H, Severt L, Shanker V, Swan MC, Soto-Valencia J, Johannes B, Ortega R, Fahn S, Cote L, Waters C, Mazzoni P, Ford B, Louis E, Levy O, Rosado L, Ruiz D, Dorovski T, Pauciulo M, Nichols W, Orr-Urtreger A, Ozelius L, Clark L, Giladi N, Bressman S, Marder KS.

Mov Disord. 2013 Dec;28(14):1966-71. doi: 10.1002/mds.25647. Epub 2013 Oct 15.

Bimanual force coordination in Parkinson's disease patients with bilateral subthalamic deep brain stimulation

Gorniak SL, McIntyre CC, Alberts JL.

PLoS One. 2013 Nov 11;8(11):e78934. doi: 10.1371/journal.pone.0078934. eCollection 2013.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias